Clinical trial
Destination Therapy Post Approval Study
NCT03681210
Study timeline
Study start (actual)2018-10-31Date precision: day
Registry last updated2025-08-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Chronic Heart Failureunresolved
Interventions
Sponsors & collaborators
Medtronic Cardiac Rhythm and Heart Failurelead sponsor
Mapped research locations
HoustonTexas, United States3New YorkNew York, United States2BostonMassachusetts, United States2DallasTexas, United States2BaltimoreMaryland, United States2ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1St LouisMissouri, United States1San AntonioTexas, United States1NashvilleTennessee, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03681210 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.